← Back to Search

Yoga for Scleroderma (GYYB Trial)

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women fulfilling the 2013 ACR/EULAR Classification for Systemic Sclerosis
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether yoga and breathing exercises can help manage symptoms in scleroderma patients. Two clinic visits and regular at-home practice over 3 months.

Who is the study for?
This trial is for men and women over 18 with any form of scleroderma, who are currently receiving treatment. Participants must be able to do gentle chair-based yoga movements and breathing exercises, have a working phone, and the ability to watch instructional videos online. It's not for those with psychiatric conditions that affect consent-giving, physical limitations preventing yoga practice, or anyone already doing regular yoga or in another yoga study.
What is being tested?
The study tests if gentle yoga and yogic breathing can help manage symptoms in scleroderma patients. It involves initial training at MUSC followed by twice-daily home practice using video guidance for 12 weeks. Progress is tracked through diaries and weekly calls from the coordinator.
What are the potential side effects?
Since this intervention involves only gentle movement and breathing exercises tailored for individuals with scleroderma, significant side effects are unlikely; however, participants may experience mild discomfort or muscle soreness typical of starting a new exercise regimen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with systemic sclerosis according to the 2013 criteria.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptance
Adherence
Depression
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: GYYBExperimental Treatment1 Intervention
This is a single-arm pre-post design.

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
977 Previous Clinical Trials
7,400,957 Total Patients Enrolled
3 Trials studying Scleroderma
450 Patients Enrolled for Scleroderma
Paul NietertUNKNOWN
Richard SilverUNKNOWN
Marvella FordUNKNOWN
Therese KilleenUNKNOWN

Media Library

GYYB Clinical Trial Eligibility Overview. Trial Name: NCT04491396 — N/A
Scleroderma Research Study Groups: GYYB
Scleroderma Clinical Trial 2023: GYYB Highlights & Side Effects. Trial Name: NCT04491396 — N/A
GYYB 2023 Treatment Timeline for Medical Study. Trial Name: NCT04491396 — N/A
~3 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top